Albosdi Tablet
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
MFDS item code 201905081 · Approved 2019.07.19
This product's status changed to Approval withdrawn on 2024.01.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis) and prevention of Mendelson's syndrome
This medication is used to treat gastric and duodenal ulcers, gastritis, and gastrointestinal diseases such as Zollinger-Ellison syndrome. It also helps in the treatment of gastroesophageal reflux disease. It may be administered before anesthesia to prevent Mendelson's syndrome, and it is effective for ulcer treatment post-surgery. It is also used to treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to improve various gastrointestinal disorders.
Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet three times daily and increase the dose as needed. In severe disease, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with allergies to any of its components. It should also be avoided in patients with a history of acute porphyria, and it is considered safe to not administer it in patients with impaired renal function or those who have undergone upper gastrointestinal surgery. Women who are pregnant or may become pregnant, premature infants, newborns, and patients on a potassium-restricted diet should also refrain from using this medication. Patients with liver dysfunction, a history of drug allergies, the elderly, and those with renal dysfunction should use this medication cautiously. If taking NSAIDs, regular monitoring is required, especially for the elderly or those with a history of peptic ulcers. In gastric ulcer patients, symptoms of gastric cancer may be masked; therefore, middle-aged or older patients with newly developed dyspepsia should verify the malignancy before treatment. Patients with Helicobacter pylori infection associated with gastric and duodenal ulcers should undergo eradication therapy, and extreme caution is required in critically ill patients, those with hypophosphatemia, or patients with swallowing difficulties. During the intake of this medication, there may be anaphylactic shock or hypersensitivity reactions such as skin rash and angioedema; if symptoms occur, discontinue the medication immediately and consult a physician. Various adverse reactions such as blood abnormalities, liver dysfunction, arrhythmia, gastrointestinal symptoms, neurological disturbances, myalgia, skin rashes, etc., have been reported; if any abnormal symptoms appear, consult medical personnel immediately. Long-term use should be avoided, and treatment should be closely monitored; if no effect is observed, it is advisable to switch to another medication. Elderly patients or those with chronic lung disease, diabetes, or immunocompromised states may see an increased risk of developing epidemic pneumonia while taking this medication. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. There may be interactions with other drugs; thus, if taking other medications, it is essential to inform medical staff, especially when using anticoagulants, antibiotics, or anticonvulsants. It is safer for pregnant or breastfeeding women to avoid using this medication, and safety in pediatrics is not well established. Since it can affect test results, care must be taken during clinical tests, and in case of overdose, seek appropriate treatment immediately from a medical institution. This medication can reduce gastric acid secretion and promote bacterial overgrowth in the stomach, so ophthalmological examination may be required upon long-term administration.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. This storage method helps to maintain the medication’s efficacy.
Greenish rectangular film-coated tablets
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.